Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.15M Buy
9,602
+50
+0.5% +$5.71K 0.07% 288
2021
Q1
$1M Buy
9,552
+50
+0.5% +$5.07K 0.07% 298
2020
Q4
$967K Hold
9,502
0.07% 238
2020
Q3
$799K Buy
9,502
+300
+3% +$23.4K 0.06% 231
2020
Q2
$598K Hold
9,202
0.05% 268
2020
Q1
$599K Sell
9,202
-243
-3% -$19.1K 0.07% 244
2019
Q4
$744K Hold
9,445
0.07% 278
2019
Q3
$752K Sell
9,445
-399
-4% -$31.4K 0.07% 261
2019
Q2
$823K Buy
9,844
+1,843
+23% +$147K 0.08% 245
2019
Q1
$632K Hold
8,001
0.07% 257
2018
Q4
$534K Hold
8,001
0.07% 257
2018
Q3
$639K Buy
8,001
+201
+3% +$15K 0.07% 277
2018
Q2
$526K Buy
7,800
+200
+3% +$14.5K 0.06% 292
2018
Q1
$585K Buy
7,600
+500
+7% +$37K 0.06% 275
2017
Q4
$484K Hold
7,100
0.05% 304
2017
Q3
$394K Hold
7,100
0.05% 319
2017
Q2
$394K Buy
7,100
+900
+15% +$46.9K 0.05% 321
2017
Q1
$311K Buy
+6,200
New +$302K 0.05% 336

Other funds holding XYL

USCA RIA's XYL Position: Q2 2021 in Review

USCA RIA increased its Xylem (XYL) stake by 0.52% in Q2 2021, buying an estimated $5.71K and bringing the position to 9,602 shares worth $1.15M. The position accounts for 0.07% of the portfolio, ranked #288.

USCA RIA first reported a position in XYL in Q1 2017 and has held it in 18 quarters since. 771 funds tracked by Wall St. Rank hold XYL as of Q2 2021.

  • USCA RIA held 9,602 shares of Xylem worth $1.15M as of Q2 2021.
  • USCA RIA bought 50 Xylem shares in Q2 2021, an estimated $5.71K.
  • Xylem made up 0.07% of USCA RIA's portfolio in Q2 2021, its #288 holding.
  • USCA RIA first reported a position in Xylem in Q1 2017 and has held it in 18 quarters since.
  • 771 funds tracked by Wall St. Rank held Xylem as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.